Oral administration of antigen has been shown to be effective for both positive and negative modulation of immune responses. In the present study we characterized changes in the reactivity of the immune system after oral immunization with allogeneic spleen cells. Mice were orally immunized for 10 consecutive days with fresh allogeneic spleen cells, and the phenotype, proliferative response, cytotoxic activity and cytokine production profile of recipient spleen cells were assessed 1 or 7 days after the last immunization dose. Although no significant changes in the proportion of CD4+, CD8+ or CD25+ cells were observed in the spleen of orally immunized mice, significant activation of alloreactivity in spleen cells was found. Cells from orally immunized mice exhibited enhanced proliferation and cytotoxic activity after stimulation with specific allogeneic cells in vitro, and produced considerably higher concentrations of interferon-gamma (IFN-gamma) and significantly less interleukin (IL)-4 than did cells from control mice. The production of IL-2 was essentially unchanged and that of IL-10 was only slightly increased. The systemic allosensitization induced by oral immunization was demonstrated in vivo by increased resistance to the growth of allogeneic tumours induced by subcutaneous inoculation of high doses of tumour cells. In addition, orthotopic corneal allografts in orally immunized recipients were rejected more rapidly (in a second-set manner) than in control, untreated recipients. These data show that oral immunization with allogeneic cells modulates individual components of the immune response and that specific transplantation immunity, rather than tolerance, is induced in the treated recipients.

Institute of Molecular Genetics Academy of Sciences of the Czech Republic Prague Faculty of Natural Sciences Charles University Prague Department of Ophthalmology Charles University Prague Czech Republic

Zobrazit více v PubMed

Weiner HL, Friedman A, Miller A, et al. Oral tolerance: immunological mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–37. PubMed

Sayegh MH, Zhang ZJ, Hancock WW, Kvok CA, Carpenter CB, Weiner HL. Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization of skin allografts by orally administered alloantigen. Transplantation. 1992;53:163–6. PubMed

He Y-G, Mellon J, Niederkorn JY. The effect of oral immunization on corneal allograft survival. Transplantation. 1996;91:920–6. PubMed

Garside P, Mowat AM. Mechanisms of oral tolerance. Crit Rev Immunol. 1997;17:119–37. PubMed

Yang DM, Fairweather N, Button LL, McMaster WR, Kahl LP, Liew FY. Oral Salmonella typhimurium AroA– vaccine expressing a major leishmanial surface protein gp63 preferentially induces T helper 1 cells and protective immunity against leishmaniasis. J Immunol. 1990;145:2281–5. PubMed

Peng H-J, Turner MW, Strobel S. The kinetics of oral hyposensitization to a protein antigen are determined by immune status and the timing, dose and frequency of antigen administration. Immunology. 1989;67:425–30. PubMed PMC

Faria AMC, Garcia G, Rios MJC, Michalaros CL, Vaz NM. Decrease in susceptibility to oral tolerance induction and occurrence of oral immunization to ovalbumin in 20-week-old mice: the effect of interval between oral exposures and rate of antigen intake in the oral immunization. Immunology. 1993;78:147–51. PubMed PMC

Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dose. Proc Natl Acad Sci USA. 1994;91:6688–92. PubMed PMC

Ma D, Li X-Y, Mellon J, Niederkorn JY. Immunological phenotype of host orally immunized with corneal alloantigens. Invest Opthalmol Vis Sci. 1998;39:744–53. PubMed

Marth T, Strober W, Kelsall BI. High dose oral tolerance in ovalbumin TCR– transgenic mice: systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis. J Immunol. 1996;157:2348–57. PubMed

Chen Y, Inobe J-I, Weiner HL. Inductive events in oral tolerance in the TCR transgenic adoptive transfer mode. Cell Immunol. 1997;178:62–8. 10.1006/cimm.1997.1119. PubMed DOI

Tonkonogy SL, Swain SL. Distinct lymphokine production by CD4+ T cells isolated from mucosal and systemic lymphoid organs. Immunology. 1993;80:574–80. PubMed PMC

Ma D, Mellon J, Niederkorn JY. Oral immunization as a strategy for enhancing corneal allograft survival. Br J Ophthalmol. 1997;81:778–84. PubMed PMC

Holáň V, Mitchison NA. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens. Eur J Immunol. 1993;13:652–7. PubMed

Holáň V, Sedláč ková K, Rů ž ič ková M. Production of high levels of Th1 and Th2 cytokines in mice with acquired transplantation tolerance. Cell Immunol. 1996;174:7–12. 10.1006/cimm.1996.0287. PubMed DOI

Bubenı´k J, Indrová M, Ně meč ková Š, Malkovský M, von Broen B, Pálek V, Andrlı´ková J. Solubilized tumour-associated antigens of methylcholanthrene-induced sarcomas. Comparative studies by in vitro sensitization of lymph-node cells, macrophage electrophoretic mobility assay and transplantation tests. Int J Cancer. 1987;21:348–55. PubMed

Holáň V, Kuffová L, Zajı´cová A, Krulová M, Filipec M, Holler P, Janč árek A. Urocanic acid enhances IL-10 production in activated CD4+ T cells. J Immunol. 1998;161:3237–41. PubMed

She S-C, Steahly LP, Moticka MJ. A method for performing full-thickness, orthotopic, penetrating keratoplasty in the mouse. Opthalmic Surg. 1990;21:781–5. PubMed

Holáň V, Hašková Z, Filipec M. Transplantation immunity and tolerance in the eye Rejection and acceptance of orthotopic corneal allografts in mice. Transplantation. 1996;62:1050–4. PubMed

Gorczynski RM, Chen Z, Zeng H, Fu XM. A role of persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization. Transplantation. 1998;66:339–49. PubMed

Ishido N, Matsuoka J, Matsuno T, Nakagawa K, Tanaka N. Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes. Transplantation. 1999;68:1377–82. PubMed

Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice. Evidence that the immunogenetics rules of rejection do not apply. Transplantation. 1992;54:694–704. PubMed

Hašková Z, Usiu A, Pepose JS, Ferguson TA, Stuart PM. CD4+ T cells are critical for corneal, but not skin, allograft rejection. Transplantation. 2000;69:483–7. PubMed

McMenamin C, Pimm C, McKersey M, Holt PG. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science. 1994;265:1869–71. PubMed

Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice. Systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis. J Immunol. 1996;157:2348–57. PubMed

Chen Y, Inobe J, Weiner HL. Induction of oral tolerance to myelin basic protein in CD8-depleted mice. J Immunol. 1995;155:910–6. PubMed

Hancock WW, Polanski M, Yhang J, Blogg A, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am J Pathol. 1995;147:1193–9. PubMed PMC

McMenamin C, Holt PG. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med. 1993;178:889–99. PubMed PMC

George A. Generation of gamma interferon response in murine Peyer's patches following oral immunization. Infect Immun. 1996;64:4606–11. PubMed PMC

Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991;5:171–7. PubMed

Seder RA, Paul WE. Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu Rev Immunol. 1994;12:625–73. PubMed

Chen A, Field E. Enhanced type 2 and diminished type 1 cytokines in neonatal tolerance. Transplantation. 1995;59:933–41. PubMed

Onodera K, Hancock WW, Graser E, Volk HD, Lehmann M, Chandraker A, Sayegh MH, Kupiec-Weglinski JW. Th2-type cytokines in the ‘infectious’ tolerance pathway. Transplant Proc. 1997;29:1290–1. 10.1016/S0041-1345(96)00522-2. PubMed DOI

Frič J, Krulová M, Zajı´cová A, Holáč V. Phenotype, immunological reactivity and cytokine production profile of Peyer's patch cells from mice immunized orally with allogeneic cells. Folia Biol (Praha) 2000;46:119–25. PubMed

Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice